# A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors

> **NCT00251797** · PHASE1 · COMPLETED · sponsor: **University of New Mexico** · enrollment: 10 (actual)

## Conditions studied

- Brain and Nervous System
- Cancer

## Interventions

- **DRUG:** Irinotecan
- **DRUG:** Thalidomide

## Key facts

- **NCT ID:** NCT00251797
- **Lead sponsor:** University of New Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-03
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2010-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00251797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00251797, "A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00251797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*